These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20488299)

  • 21. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
    Khatib R; Joseph P; Briel M; Yusuf S; Healey J
    Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.
    Novo G; Guttilla D; Fazio G; Cooper D; Novo S
    Br J Clin Pharmacol; 2008 Sep; 66(3):345-51. PubMed ID: 18782141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of atrial fibrillation in hypertension.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    Curr Hypertens Rep; 2008 Jun; 10(3):175-81. PubMed ID: 18765086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
    Lau YF; Yiu KH; Siu CW; Tse HF
    J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of RAAS blockers on adverse clinical outcomes in high CVD risk subjects with atrial fibrillation: A meta-analysis and systematic review of randomized controlled trials.
    Chaugai S; Sherpa LY; Sepehry AA; Arima H; Wang DW
    Medicine (Baltimore); 2016 Jun; 95(26):e4059. PubMed ID: 27368043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation.
    Hung CY; Hsieh YC; Li CH; Huang JL; Lin CH; Wu TJ
    Sci Rep; 2015 Jun; 5():11442. PubMed ID: 26094981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
    Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
    Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation: An overview of systematic reviews.
    Yu Z; Zhang D; Ji Q; Yi F
    Medicine (Baltimore); 2021 May; 100(18):e25559. PubMed ID: 33950930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation After Catheter Ablation.
    Zhao J; Chen M; Zhuo C; Huang Y; Zheng L; Wang Q
    Int Heart J; 2020 Nov; 61(6):1174-1182. PubMed ID: 33191354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.
    Durin O; Pedrinazzi C; Inama G
    J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS; Coleman CI; White CM
    J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ranolazine in the prevention and treatment of atrial fibrillation: A meta-analysis of randomized clinical trials.
    Gong M; Zhang Z; Fragakis N; Korantzopoulos P; Letsas KP; Li G; Yan GX; Liu T
    Heart Rhythm; 2017 Jan; 14(1):3-11. PubMed ID: 27746384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role Of Renin Angiotensin System In Atrial Fibrillation.
    Nair GM; Nery PB; Redpath CJ; Birnie DH
    J Atr Fibrillation; 2014; 6(6):972. PubMed ID: 27957054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.
    Disertori M; Barlera S; Staszewsky L; Latini R; Quintarelli S; Franzosi MG
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):47-54. PubMed ID: 22009136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the renin angiotensin system blocking in the management of atrial fibrillation.
    Soran H; Ziglam H; Al-Najjar M; Younis N
    Acta Cardiol; 2008 Aug; 63(4):457-65. PubMed ID: 18795583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.
    Horio T; Akiyama M; Iwashima Y; Yoshihara F; Nakamura S; Tokudome T; Okutsu M; Tanaka H; Komatsubara I; Okimoto N; Kamakura S; Kawano Y
    J Hum Hypertens; 2017 Jul; 31(7):450-456. PubMed ID: 28032630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.